PubRank

Jingshu Wang

Author PubWeight™ 16.12‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Burden of concomitant asthma and COPD in a Medicaid population. Chest 2008 1.87
2 School-based obesity interventions: a literature review. J Sch Health 2008 1.55
3 Effect of medication burden on persistent use of lipid-lowering drugs among patients with hypertension. Am J Manag Care 2008 1.54
4 Disparities among older adults in measures of cognitive function by race or ethnicity. J Gerontol B Psychol Sci Soc Sci 2005 1.43
5 Quercetin suppresses cyclooxygenase-2 expression and angiogenesis through inactivation of P300 signaling. PLoS One 2011 1.12
6 Berberine Targets AP-2/hTERT, NF-κB/COX-2, HIF-1α/VEGF and Cytochrome-c/Caspase Signaling to Suppress Human Cancer Cell Growth. PLoS One 2013 1.02
7 Melatonin suppresses proinflammatory mediators in lipopolysaccharide-stimulated CRL1999 cells via targeting MAPK, NF-κB, c/EBPβ, and p300 signaling. J Pineal Res 2012 1.01
8 Nicotine promotes proliferation of human nasopharyngeal carcinoma cells by regulating α7AChR, ERK, HIF-1α and VEGF/PEDF signaling. PLoS One 2012 0.97
9 Quality of Life and Utility in Patients with Metastatic Soft Tissue and Bone Sarcoma: The Sarcoma Treatment and Burden of Illness in North America and Europe (SABINE) Study. Sarcoma 2012 0.95
10 TFAP2A regulates nasopharyngeal carcinoma growth and survival by targeting HIF-1α signaling pathway. Cancer Prev Res (Phila) 2013 0.91
11 REG I enhances chemo- and radiosensitivity in squamous cell esophageal cancer cells. Cancer Sci 2008 0.83
12 Regenerating gene I regulates interleukin-6 production in squamous esophageal cancer cells. Biochem Biophys Res Commun 2010 0.80
13 Sexual dimorphism in LEC rat liver: suppression of carbonic anhydrase III by copper accumulation during hepatocarcinogenesis. Biomed Res 2011 0.77
14 A novel monoclonal antibody identified hepatic stem-like cells in rats. Med Mol Morphol 2011 0.77
15 TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF/PEDF signaling. Mol Cancer 2014 0.76